PNT — POINT Biopharma Global Share News
0.000.00%
Last trade - 00:00HealthcareSpeculativeMid Cap
- $1.33bn
- $998.03m
- $226.58m
Fusion Pharma gains on Bristol Myers-RayzeBio deal
Brief: Point Biopharma- Lilly Offer Expired And Not Further Extended - SEC Filing
Brief: BVF Partners Dissolves Share Stake In Point Biopharma Global
U.S. STOCKS ON THE MOVE-Biomerica, Netflix, SunPower
Lantheus, Point Bio slide as cancer drug data misses expectations
Brief: Lilly Extends Tender Offer to Acquire POINT Biopharma to Dec. 22
Deals of the day-Mergers and acquisitions
Brief: Lilly Extends Tender Offer To Acquire Point Biopharma To Dec. 15, 2023
Eli Lilly extends tender offer to buy Point Biopharma to Dec. 15 (updated)
Eli Lilly extends tender offer to buy Point Biopharma
Eli Lilly’s M&A trial prints lose-lose outcome
Deals of the day-Mergers and acquisitions
Eli Lilly extends tender offer to buy Point Biopharma after low participation (updated)
Lilly extends tender offer to acquire Point Biopharma to Dec 1
Brief: Lilly Extends Tender Offer To Acquire Point Biopharma To December 1, 2023
Brief: Lilly Announces Receipt Of NRC Consent In Connection With Its Proposed Acquisition Of Point Biopharma
Brief: Lilly Announces Extension Of Tender Offer To Acquire Point Biopharma
Brief: BVF Partners L.P. Says Closing Eli Lilly Deal Not In Favor Of Point Biopharma's Shareholders
U.S. RESEARCH ROUNDUP-B&G Foods, General Motors Co, Point Biopharma Global